EUMCA Founding Members
Bundesverband der Pharmazeutischen Industrie e.V.
We advocate for politics, external stakeholders and the public for a location policy that secures jobs, drives pharmaceutical innovations and does justice to the permanent and cross-party task: To ensure the future-oriented improvement of patient health care!
Tilray is a global leader in cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis and hemp company.
A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.
Materia Ventures is a strategic supplier and distributor of high-quality medical cannabis and CBD products to the burgeoning European market. With an extensive GMP manufacturing and formulation footprint across the EU, we serve the growing cannabis and CBD markets.
Panaxia is modernizing the medical field with revolutionary pharmaceutical solutions that utilize the unique properties and benefits of medical cannabis. As a leader in this rapidly developing medical arena, Panaxia is spearheading the adoption of cannabis-based treatments through a variety of familiar delivery methods that can radically improve the lives of those with a wide range of medical conditions.
COMM-OP EUROPE is a one-stop shopping platform offering consultancy and support in market entry management in the healthcare market for medicinal products (OTC, Rx, Orphan), food supplements, medical food and medical devices.
As a fully licensed importer of cannabinoid drugs, we consider it our duty to ensure that patients, doctors and pharmacists have the best possible access to products, studies and information of the highest quality.
We are working on a holistic solution for the transparent and sustainable cultivation, processing and distribution of medical cannabis to the highest standards. Our focus is on reliably supplying the growing demand of a growing number of patients with high-quality cannabinoid drugs.
Ethical Medicines Industry Group
EMIG is a network of life sciences companies and organisations with an influential voice in government, working to advance patient access to medicines.
EMIG is a multi-stakeholder network and trade industry association that represents the interests of the full span of life sciences companies in the UK. Our industry Members, range from new business start-ups focused on R&D, through to well-established companies delivering a wide range of essential medicines to patients.
Iqanna is the pharmaceutical arm of the Clever Leaves Group. Clever Leaves is dedicated to the innovation, development and commercialization of pharmaceutical grade cannabis. By partnering with local governments and regulators around the world, we are building the pathways of a legal and fully global medical cannabis ecosystem.
We believe in the power of medical cannabis and are dedicated to advancing this cause for our patients and helping improve their quality of life.
Medcann World Forum – Malta
Leading Medical Cannabis confernce in Malta. Medcann is the Mediterranean’s premier medical cannabis conference in Malta, bringing together global industry experts and professionals.